Yong Yang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmacology top 0.5%
- Flavonoids in Medical Research
Papers in
-
- Protein Degradation and Inhibitors 6
- Oncology 28
- Co-authors
- Qinglong Guo (31 shared papers)Qidong You (30 shared papers)Na Lu (23 shared papers)Hong-Yan Gu (19 shared papers)Qiuhua Cao (10 shared papers)Xinghua Gao (9 shared papers)Qi Qi (21 shared papers)Hongbao Yang (10 shared papers)
- Journals
- Cancer Letters (10 papers)European Journal of Pharmacology (7 papers)Cell Death and Disease (4 papers)Phytotherapy Research (3 papers)Journal of Controlled Release (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yong Yang
124 papers receiving 6.2k citations
Yong Yang's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 1.3k
- Pharmacology 967
- Biochemistry 401
- Molecular Biology 3.3k
- Biological Psychiatry 104
Countries citing papers authored by Yong Yang
This map shows the geographic impact of Yong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yang more than expected).
Fields of papers citing papers by Yong Yang
This network shows the impact of papers produced by Yong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yang. The network helps show where Yong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quercetin alleviates acute kidney injury by inhibiting ferroptosis Hit paper breakdown → | 2020 | 464 |
| 2 | A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer? Hit paper breakdown → | 2018 | 343 |
| 3 | ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury Hit paper breakdown → | 2022 | 307 |
| 4 | Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response Hit paper breakdown → | 2018 | 295 |
| 5 | 2018 | 231 | |
| 6 | 2007 | 211 | |
| 7 | 2010 | 173 | |
| 8 | 2020 | 172 | |
| 9 | 2009 | 171 | |
| 10 | 2007 | 149 | |
| 11 | 2007 | 127 | |
| 12 | 2015 | 126 | |
| 13 | 2018 | 105 | |
| 14 | 2020 | 89 | |
| 15 | 2007 | 88 | |
| 16 | 2020 | 88 | |
| 17 | 2020 | 86 | |
| 18 | 2008 | 85 | |
| 19 | 2009 | 83 | |
| 20 | 2021 | 81 |
About Yong Yang
Yong Yang is a scholar working on Molecular Biology, Oncology, Pharmacology, Immunology and Pulmonary and Respiratory Medicine, having authored 130 papers that have together received 6.3k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (13 papers), Natural Compound Pharmacology Studies (11 papers), Synthesis of Organic Compounds (10 papers), Ferroptosis and cancer prognosis (9 papers), Immune cells in cancer (8 papers), Cancer, Lipids, and Metabolism (7 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Cancer Research (1.3k citations), Pharmacology (967 citations), Biochemistry (401 citations), Molecular Biology (3.3k citations) and Biological Psychiatry (104 citations). Yong Yang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Qinglong Guo, Qidong You, Na Lu, Hong-Yan Gu, Qiuhua Cao, Xinghua Gao, Qi Qi, Hongbao Yang, Xianjing Li and Jin‐Song Bian. Their work appears in journals such as Cancer Letters, European Journal of Pharmacology, Cell Death and Disease, Phytotherapy Research and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.